Do not restart tirzepatide and contact your healthcare team if you cannot keep fluids down for more than 4-6 hours, experience persistent vomiting for over 24 hours, have severe abdominal pain, or have blood glucose levels consistently above 300 mg/dL
Our proprietary blend, called Ortho Restore, combines these peptides to maximize their synergistic effects
NHS guidance recommends a sustainable fat loss rate of 0.51 kg per week, assessed over weeks to months rather than individual days
Developed by Novo Nordisk, Ozempic is a once-weekly injectable medication that mimics the effects of a naturally occurring hormone called glucagon-like peptide-1 (GLP-1)
The combination of enhanced fat metabolism, appetite control, delayed gastric emptying, and improved blood sugar management by increasing insulin sensitivity typically leads to weight loss in individuals using Semaglutide
MK-801 is widely used experimentally, but its clinical application is hampered by severe adverse effects